Crohn's disease trials in Kazakhstan

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

  Where

  Almaty, Astana, Karaganda, Shymkent

  Age

  18 years to 85 years

  People

  385 worldwide

  Run by

  Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)

  See details and how to joinNCT06226883 · EU 2023-508158-24-00